Topics

Tiziana Life Sciences plc Company Profile

22:05 EDT 15th September 2019 | BioPortfolio

Tiziana Life Sciences plc is a UK biotechnology company that focuses on the discovery and development of novel molecules that treat human disease in oncology and immunology. The Company is focused on its lead compound milciclib. The Company is also in clinical development of foralumab. Foralumab is the only fully human engineered anti-human CD3 antibody in clinical development. This phase II compound has potential application in a wide range of autoimmune and inflammatory diseases, such as nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBS), ulcerative colitis, multiple sclerosis, type-1 diabetes (T1D), inflammatory bowel disease (IBD), psoriasis and rheumatoid arthritis, where modulation of a T-cell response is desirable.


News Articles [2264 Associated News Articles listed on BioPortfolio]

Tiziana files IND for oral formulation of drug for NASH, liver disease

An investigational new drug application was filed by Tiziana Life Sciences with the FDA for an early-stage study of enteric-c -More- 

Tiziana's Foralumab can be biggest disruptor to medical industry 'in a decade'

Chairman and founder of Tiziana Life Sciences plc (LON:TILS) Gabriele Cerrone introduces Proactive London's Andrew Scott to their two lead programmes - one focused on liver cancer and the other on a...

Tiziana reveals positive results for Milciclib in liver cancer trial

Tiziana Life Sciences has reported that Milciclib was well-tolerated in a Phase IIa clinical trial involving participants with advanced hepatocellular...Read More... The post Tiziana reveals positive ...

Tiziana Reports Phase 1 Clinical Data of Nasal Treatment

Tiziana Life Sciences (NASDAQ:TLSA) has announced Phase 1 clinical data of its nasally administered Foralumab. As quoted in the press release: Importantly, the treatment showed significant positive ef...

Tiziana Life Sciences has sights set high as it awaits key clinical data

This month and next has major pieces of news scheduled from the Aim and Nasdaq listed biotech

5 Ways To Keep Your Life Sciences Startup From Becoming Theranos

Bio-IT World Contributed Commentary | Transparency is critical for all industries these days, but especially for the life sciences sector. When it comes to innovative services and products from e...

Tiziana submits IND for Foralumab oral formulation in NASH

Tiziana has submitted an Investigational New Drug application for an oral formulation of Foralumab.

California Life Sciences Fueled by Education, Established Companies

New medicines, devices, and diagnostics produced by the life sciences community in California are giving clinicians better tools to fight disease and improve quality of life for patients around the wo...

Drugs and Medications [45 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (e...

PubMed Articles [2835 Associated PubMed Articles listed on BioPortfolio]

ALBAN FREI, Sichtbare Netzwerke. Forschungspolitik und Life-Sciences zwischen 1990 und 2016 in der Schweiz. Eine Fallstudie zu SystemsX.ch, Zürich: Chronos Verlag, 2018, 272 pp., CHF 38.00/EUR 38.00.

Genetically Modified Organisms in Developing Countries: Risk Analysis and Governance.

Introduction to the Special Issue on Biotechnological Frontiers.

Short-term disability fluctuations in late life.

Late-life disability is highly dynamic but within-person short-term fluctuations have not been assessed previously. We analyze how substantial such late-life disability fluctuations are and whether th...

Greater Peri-Aortic Fat Volume at Midlife is Associated with Slower Gait Speed Later in Life in Women: The SWAN Cardiovascular Fat Ancillary Study.

Higher perivascular adipose tissue (PVAT) contributes to adverse physiologic alterations in the vascular wall, and thus could potentially limit normal physical function later in life. We hypothesize t...

Clinical Trials [2599 Associated Clinical Trials listed on BioPortfolio]

Advance Care Planning at London Health Sciences Centre

All patients admitted to London Health Sciences Centre (LHSC) are asked to indicate their preferences for CPR (cardiopulmonary resuscitation) and other life-sustaining treatments that nece...

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Assessment of the Burden Within the Dyad Patient/Caregiver

This study is about the patients life ending and their caregiver, when a return to home is planned. This is a behavioral sciences study (= interventional study for french law)

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

Companies [2082 Associated Companies listed on BioPortfolio]

Tiziana Life Sciences plc

Tiziana Life Sciences plc is a UK biotechnology company that focuses on the discovery and development of novel molecules that treat human disease in oncology and immunology. The C...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Blackstone Life Sciences

Blackstone Life Sciences is a private investment platform with capabilities to invest across the life-cycle of companies and products within the key life science sectors. By combi...

Central Life Sciences

Central Life Sciences is a strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, ...

California Life Sciences Institute

California Life Sciences Institute (CLSI) supports the foundations of innovation that have made California home to the world’s most prominent life sciences ecosystem. With a ...

More Information about "Tiziana Life Sciences plc" on BioPortfolio

We have published hundreds of Tiziana Life Sciences plc news stories on BioPortfolio along with dozens of Tiziana Life Sciences plc Clinical Trials and PubMed Articles about Tiziana Life Sciences plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tiziana Life Sciences plc Companies in our database. You can also find out about relevant Tiziana Life Sciences plc Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...


Corporate Database Quicklinks



Searches Linking to this Company Record